Phathom Pharmaceuticals to Present VOQUEZNA(TM) (vonoprazan) Data at DDW 2024 Annual Meeting
Stockwatch,
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting First oral presentation of Phase 3…
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting First oral presentation of Phase 3…
First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD)1…
First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD)1…
First oral presentation of Phase 3 dataevaluating the investigational use of VOQUEZNA® inNon-Erosive Reflux Disease (NERD)1 New…